Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea · Delayed Price · Currency is KRW 2,435.00
+50.00 (2.10%)
At close: Aug 20, 2026
Kangstem Biotech Market Cap
Kangstem Biotech has a market cap or net worth of 229.02 billion as of August 20, 2026. Its market cap has increased by 229.23% in one year.
Market Cap
229.02B
Enterprise Value
210.80B
Revenue
3.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,435.00
ChartMarket Cap Chart
Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 229.02B, an increase of 77.09%. That is a compound annual growth rate of 5.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 229.02B | 4.96% |
| Dec 30, 2025 | 218.21B | 92.71% |
| Dec 30, 2024 | 113.23B | -15.48% |
| Dec 28, 2023 | 133.97B | 21.98% |
| Dec 29, 2022 | 109.83B | -11.47% |
| Dec 30, 2021 | 124.06B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 404.96B |
| Curocell | 398.19B |
| IntoCell | 334.24B |
| HansBiomed | 293.07B |
| IMBiologics | 256.11B |
| Genome & Company | 241.62B |
| S.Biomedics | 238.91B |
| curacle co.,ltd. | 233.49B |